DiaMedica Therapeutics (DMAC) Institutional Ownership → **Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! (From Huge Alerts) (Ad) Free DMAC Stock Alerts $3.03 -0.14 (-4.42%) (As of 03:02 PM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for DiaMedica Therapeutics (NASDAQ:DMAC)CurrentInstitutional OwnershipPercentage10.12%Number ofInstitutional Buyers(last 12 months)6TotalInstitutional Inflows(last 12 months)$838.69KNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$563.24K Get DMAC Insider Trade Alerts Want to know when executives and insiders are buying or selling DiaMedica Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data DMAC Institutional Buying and Selling by Quarter Ad Priority GoldRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.Click here for your free guide DiaMedica Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/10/2024 Vanguard Group Inc.1,013,522$2.81M0.0%+26.3%2.670% 2/15/2024 Paragon Associates & Paragon Associates II Joint Venture500,000$1.42M3.3%+6.4%1.318% 2/7/2024 Avantax Advisory Services Inc.12,500$36K0.0%N/A0.033% 11/15/2023 Stonebridge Capital Advisors LLC20,000$52K0.0%N/A0.053% 11/13/2023 EAM Investors LLC212,512$548K0.1%-21.4%0.560% 11/9/2023 Bleichroeder LP222,317$574K0.1%-24.4%0.586% **Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! (Ad)Learn more about why Zack’s has increased its price target on this company to a whopping $23.25!Click for Zack's full report11/1/2023Jacob Asset Management of New York LLC168,730$435K0.6%-15.1%0.445% 8/30/2023 Cooperman Leon G875,993$3.78M0.2%+0.9%2.308% 8/10/2023Jacob Asset Management of New York LLC198,730$859K1.0%-15.0%0.738% 8/2/2023 Catalyst Financial Partners LLC36,267$157K0.1%+44.4%0.135% 4/11/2023 Catalyst Financial Partners LLC25,110$38K0.0%+73.5%0.095% 5/12/2022Jacob Asset Management of New York LLC265,000$663K0.4%-3.6%1.002% 2/15/2022 Stonepine Capital Management LLC1,194,670$4.46M2.0%+620.7%4.519% 11/15/2021 Marshall Wace LLP10,031$40K0.0%-93.6%0.053% 11/15/2021 Manatuck Hill Partners LLC273,100$1.10M0.4%-52.1%1.454% 11/12/2021 Stonepine Capital Management LLC165,775$665K0.3%-60.5%0.882% 11/12/2021 Jump Financial LLC18,300$73K0.0%N/A0.097% 11/9/2021 BlackRock Inc.55,970$225K0.0%-8.6%0.298% 8/25/2021 Marshall Wace LLP155,662$693K0.0%+104.9%0.829% 8/16/2021 State Street Corp30,217$134K0.0%N/A0.161% 8/16/2021Corriente Advisors LLC203,641$906K0.5%-76.6%1.084% 8/16/2021 Marshall Wace LLP155,662$693K0.0%+104.9%0.829% 8/13/2021 Renaissance Technologies LLC94,100$419K0.0%-38.5%0.501% 8/13/2021 Geode Capital Management LLC133,569$594K0.0%+4.0%0.711% 8/13/2021 Vanguard Group Inc.786,266$3.50M0.0%-7.1%4.185% 8/12/2021 Trexquant Investment LP17,019$76K0.0%N/A0.091% 8/12/2021 Dimensional Fund Advisors LP14,074$63K0.0%N/A0.075% 8/12/2021 JPMorgan Chase & Co.8,299$37K0.0%N/A0.044% 8/12/2021 Bank of Montreal Can142,846$694K0.0%+36.7%0.760% 5/21/2021 Citadel Advisors LLC20,601$189K0.0%N/A0.110% 5/19/2021 Squarepoint Ops LLC35,536$325K0.0%N/A0.189% 5/18/2021 Millennium Management LLC70,281$643K0.0%+72.0%0.374% 5/18/2021 Point72 Asset Management L.P.552,250$5.05M0.0%-31.0%2.940% 5/18/2021Corriente Advisors LLC870,228$7.96M2.9%+7.8%4.632% 5/18/2021 Citadel Advisors LLC20,601$189K0.0%N/A0.110% 5/13/2021 Barclays PLC3,412$31K0.0%N/A0.018% 5/13/2021 Renaissance Technologies LLC153,100$1.40M0.0%+35.0%0.815% 5/13/2021 Bank of New York Mellon Corp40,576$371K0.0%-5.4%0.216% 5/13/2021 Bank of Montreal Can104,524$982K0.0%+27.7%0.556% 5/12/2021 Northern Trust Corp85,026$778K0.0%-29.7%0.453% A once-in-a-century investment opportunity (Ad)It's an under-the-radar stock reshaping a projected $109 billion industry - And, I believe, has far more potential than the AI stocks most investors are focused on in the days ahead.To get its name and ticker symbol for free - just click here.5/12/2021 Geode Capital Management LLC128,468$1.18M0.0%+23.9%0.684% 5/12/2021Granite Point Capital Management L.P.184,380$1.69M0.1%-66.3%0.981% 5/11/2021 EAM Investors LLC108,232$990K0.1%-1.6%0.576% 5/7/2021 BlackRock Inc.60,165$551K0.0%+7.9%0.320% 4/27/2021 Dorsey Wright & Associates3,937$36K0.4%N/A0.021% 2/24/2021Virtu Financial LLC15,712$159K0.0%N/A0.084% 2/17/2021 Jane Street Group LLC12,537$127K0.0%N/A0.067% 2/16/2021 ExodusPoint Capital Management LP13,160$133K0.0%N/A0.070% 2/12/2021 Stonepine Capital Management LLC950,000$9.63M7.4%-17.1%5.070% 2/11/2021 Northern Trust Corp120,989$1.23M0.0%+3.6%0.646% 2/11/2021 Valeo Financial Advisors LLC5,000$51K0.0%N/A0.027% 2/10/2021 Renaissance Technologies LLC113,400$1.15M0.0%+18.1%0.605% 2/9/2021 Bank of New York Mellon Corp42,905$435K0.0%+218.5%0.229% 2/6/2021Granite Point Capital Management L.P.546,855$5.55M0.3%-15.5%2.918% 2/5/2021 BlackRock Inc.55,781$566K0.0%+27.4%0.298% 11/17/2020 Nantahala Capital Management LLC756,193$3.21M0.1%+0.8%4.035% 11/16/2020 Point72 Asset Management L.P.800,000$3.39M0.0%N/A4.269% 11/16/2020 Worth Venture Partners LLC42,887$182K0.1%N/A0.229% 11/16/2020 Manatuck Hill Partners LLC571,500$2.42M1.1%+62.8%3.050% 11/16/2020 Boothbay Fund Management LLC46,562$197K0.0%N/A0.248% 11/13/2020 Stonepine Capital Management LLC1,146,470$4.86M5.1%+71.5%6.118% 11/13/2020 Morgan Stanley9,100$38K0.0%+56.9%0.049% 11/6/2020Granite Point Capital Management L.P.646,855$2.74M0.1%+35.5%3.452% 11/3/2020Corriente Advisors LLC730,000$3.10M1.6%+262.7%3.895% 8/14/2020Corriente Advisors LLC201,248$1.40M0.9%N/A1.423% 8/12/2020 Bank of New York Mellon Corp13,472$93K0.0%N/A0.095% 5/14/2020 Stonepine Capital Management LLC825,297$2.31M2.4%N/A5.837% 5/1/2020 BlackRock Inc.38,373$108K0.0%+19.7%0.271% (Data available from 1/1/2016 forward) DMAC Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of DMAC shares? During the previous two years, 9 institutional investors and hedge funds held shares of DiaMedica Therapeutics. The most heavily invested institutionals were Cooperman Leon G ($3.78M), Vanguard Group Inc. ($2.81M), Paragon Associates & Paragon Associates II Joint Venture ($1.42M), Bleichroeder LP ($574K), EAM Investors LLC ($548K), Jacob Asset Management of New York LLC ($435K), and Catalyst Financial Partners LLC ($157K).Learn more on DMAC's institutional investors. What percentage of DiaMedica Therapeutics stock is owned by institutional investors? 10.12% of DiaMedica Therapeutics stock is owned by institutional investors. Learn more on DMAC's institutional investor holdings. Which institutional investors have been buying DiaMedica Therapeutics stock? The following institutional investors have purchased DiaMedica Therapeutics stock in the last 24 months: Vanguard Group Inc. ($211.35K), Paragon Associates & Paragon Associates II Joint Venture ($30K), Catalyst Financial Partners LLC ($21.79K), Stonebridge Capital Advisors LLC ($20K), Avantax Advisory Services Inc. ($12.50K), and Cooperman Leon G ($7.58K). How much institutional buying is happening at DiaMedica Therapeutics? Institutional investors have bought a total of 303,223 shares in the last 24 months. This purchase volume represents approximately $870.91K in transactions. Which DiaMedica Therapeutics major shareholders have been selling company stock? The following institutional investors have sold DiaMedica Therapeutics stock in the last 24 months: Bleichroeder LP ($71.80K), Jacob Asset Management of New York LLC ($65K), and EAM Investors LLC ($57.91K). How much institutional selling is happening at DiaMedica Therapeutics? Institutional investors have sold a total of 194,707 shares in the last 24 months. This volume of shares sold represents approximately $563.24K in transactions. Related Companies: Coya Therapeutics Major Shareholders Vistagen Therapeutics Major Shareholders Nuvectis Pharma Major Shareholders FibroGen Major Shareholders Adagene Major Shareholders Immunic Major Shareholders Amylyx Pharmaceuticals Major Shareholders Abeona Therapeutics Major Shareholders OptiNose Major Shareholders Rezolute Major Shareholders This page (NASDAQ:DMAC) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressDoes this make you sick?Allegiance GoldThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldUrgent Nvidia WarningAltimetryThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge Alerts Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DiaMedica Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
